NewEdge Advisors LLC Sells 5,679 Shares of Astera Labs, Inc. $ALAB

NewEdge Advisors LLC cut its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 36.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,948 shares of the company's stock after selling 5,679 shares during the quarter. NewEdge Advisors LLC's holdings in Astera Labs were worth $1,090,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ALAB. Atreides Management LP raised its position in shares of Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock valued at $368,890,000 after purchasing an additional 1,754,593 shares during the period. Amundi boosted its holdings in Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company's stock worth $278,283,000 after buying an additional 1,319,643 shares during the period. Artisan Partners Limited Partnership purchased a new position in Astera Labs in the 4th quarter valued at approximately $148,980,000. Goldman Sachs Group Inc. grew its stake in Astera Labs by 189.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company's stock valued at $218,419,000 after buying an additional 858,693 shares in the last quarter. Finally, State Street Corp raised its holdings in Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company's stock valued at $515,684,000 after acquiring an additional 760,358 shares during the period. Institutional investors own 60.47% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on ALAB shares. Weiss Ratings raised Astera Labs from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, May 21st. Barclays boosted their price objective on Astera Labs from $200.00 to $325.00 and gave the company an "equal weight" rating in a research note on Monday, July 20th. Stifel Nicolaus increased their price objective on Astera Labs from $260.00 to $460.00 and gave the stock a "buy" rating in a report on Wednesday, June 24th. TD Cowen cut their target price on Astera Labs from $425.00 to $375.00 and set a "hold" rating for the company in a research note on Wednesday, August 5th. Finally, Needham & Company LLC lifted their target price on Astera Labs from $260.00 to $425.00 and gave the company a "buy" rating in a report on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat.com, Astera Labs presently has an average rating of "Moderate Buy" and a consensus target price of $333.00.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Bethany Mayer sold 686 shares of the firm's stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total transaction of $270,997.44. Following the sale, the director owned 5,550 shares in the company, valued at $2,192,472. This trade represents a 11.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of Astera Labs stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $311.83, for a total value of $1,092,964.15. Following the sale, the director directly owned 53,961 shares of the company's stock, valued at approximately $16,826,658.63. This trade represents a 6.10% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 631,979 shares of company stock worth $215,479,247. Company insiders own 10.40% of the company's stock.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $320.17 on Tuesday. The company's fifty day moving average price is $357.48 and its 200-day moving average price is $241.79. The firm has a market capitalization of $55.55 billion, a price-to-earnings ratio of 158.50 and a beta of 3.84. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same period in the previous year, the firm posted $0.44 EPS. The firm's revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source